Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs Inks Distribution Deals

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – New England Biolabs said after the close of the market Tuesday that it has inked two new distribution agreements with Bioke and Imperial Life Sciences.

Bioke, a Dutch firm that sells reagents for signal transduction, cell culture, and molecular biology applications, serves markets in the Netherlands, Belgium, and Luxembourg. ILS supplies reagents for genomics, proteomics, cell biology, and imaging applications in India.

New England Biolabs said that it now has 39 companies worldwide in its distribution network.